{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T18:01:19Z","timestamp":1648922479132},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"19-20","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Med Wochenschr"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s10354-014-0309-6","type":"journal-article","created":{"date-parts":[[2014,10,30]],"date-time":"2014-10-30T09:07:32Z","timestamp":1414660052000},"page":"392-399","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sitting at the window to the world\u2014ocular parasites"],"prefix":"10.1007","volume":"164","author":[{"given":"Talin","family":"Barisani-Asenbauer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,31]]},"reference":[{"key":"309_CR1","doi-asserted-by":"crossref","unstructured":"Hoti SL, Tandon V. Ocular parasitoses and their immunology. Ocul Immunol Inflamm. 2011 Dec;19(6):385\u201396.","DOI":"10.3109\/09273948.2011.626141"},{"key":"309_CR2","doi-asserted-by":"crossref","first-page":"58740","DOI":"10.1155\/2012\/587402","volume":"2012","author":"AR Nimir","year":"2012","unstructured":"Nimir AR, Saliem A, Ibrahim IA. Ophthalmic parasitosis: a review article. Interdiscip Perspect Infect Dis. 2012;2012:58740\u20132.","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"309_CR3","doi-asserted-by":"crossref","unstructured":"Otranto D, Eberhard ML. Zoonotic helminths affecting the human eye. Parasit Vectors. 2011 Mar 23;4:4\u20131.","DOI":"10.1186\/1756-3305-4-41"},{"issue":"4","key":"309_CR4","doi-asserted-by":"crossref","first-page":"181\u20137","DOI":"10.1016\/j.pt.2013.01.006","volume":"29","author":"J Lorenzo-Morales","year":"2013","unstructured":"Lorenzo-Morales J, Mart\u00edn-Navarro CM, L\u00f3pez-Arencibia A, et al. Acanthamoeba keratitis: an emerging disease gathering importance worldwide? Trends Parasitol. 2013 Apr;29(4):181\u20137.","journal-title":"Trends Parasitol"},{"key":"309_CR5","doi-asserted-by":"crossref","unstructured":"Seal DV. Acanthamoeba keratitis update-incidence, molecular epidemiology and new drugs for treatment. Eye (Lond). 2003 Nov;17(8):893\u2013905.","DOI":"10.1038\/sj.eye.6700563"},{"issue":"2","key":"309_CR6","doi-asserted-by":"crossref","first-page":"70\u20139","DOI":"10.1016\/S1542-0124(12)70071-X","volume":"8","author":"N. Panjwani","year":"2010","unstructured":"Panjwani N. Pathogenesis of acanthamoeba keratitis. Ocul Surf. 2010 Apr;8(2):70\u20139.","journal-title":"Ocul Surf"},{"key":"309_CR7","doi-asserted-by":"crossref","unstructured":"Cao Z, Jefferson DM, Panjwani N. Role of carbohydrate-mediated adherence in cytopathogenic mechanisms of Acanthamoeba. J Biol Chem. 1998 Jun 9;273(25):15838\u201345.","DOI":"10.1074\/jbc.273.25.15838"},{"issue":"9","key":"309_CR8","doi-asserted-by":"crossref","first-page":"1016\u201321","DOI":"10.1097\/ICO.0b013e3181cda25c","volume":"29","author":"Y Qian","year":"2010","unstructured":"Qian Y, Meisler DM, Langston RH, Jeng BH. Clinical experience with Acanthamoeba keratitis at the cole eye institute, 1999\u20132008. Cornea. 2010 Sep;29(9):1016\u201321.","journal-title":"Cornea"},{"key":"309_CR9","doi-asserted-by":"crossref","unstructured":"Clarke B, Sinha A, Parmar DN, et al. Advances in the diagnosis and treatment of acanthamoeba keratitis. J Ophthalmol. 2012;2012:48489\u20132. doi:10.1155\/2012\/484892.","DOI":"10.1155\/2012\/484892"},{"issue":"1","key":"309_CR10","doi-asserted-by":"crossref","first-page":"1\u20138","DOI":"10.1097\/ICL.0b013e31802b64c1","volume":"33","author":"ST Awwad","year":"2007","unstructured":"Awwad ST, Petroll WM, McCulley JP, et al. Updates in Acanthamoeba keratitis. Eye Contact Lens. 2007 Jan;33(1):1\u20138.","journal-title":"Eye Contact Lens"},{"key":"309_CR11","doi-asserted-by":"crossref","unstructured":"Page MA, Mathers WD. Acanthamoeba keratitis: a 12-year experience covering a wide spectrum of presentations, diagnoses, and outcomes. J Ophthalmol. 2013;2013:670242. doi:10.1155\/2013\/670242. Epub 2013 Jun 12. PubMed PMID: 23840938; PubMed Central PMCID: PMC3694549.","DOI":"10.1155\/2013\/670242"},{"issue":"3","key":"309_CR12","doi-asserted-by":"crossref","first-page":"621\u20133","DOI":"10.1645\/0022-3395(2002)088[0621:ROACCT]2.0.CO;2","volume":"88","author":"A Aksozek","year":"2002","unstructured":"Aksozek A, McClellan K, Howard K, et al. Resistance of Acanthamoeba castellanii cysts to physical, chemical, and radiological conditions. J Parasitol. 2002 Jun;88(3):621\u20133.","journal-title":"J Parasitol"},{"issue":"3","key":"309_CR13","doi-asserted-by":"crossref","first-page":"539\u201345","DOI":"10.1093\/jac\/dkp215","volume":"64","author":"J Walochnik","year":"2009","unstructured":"Walochnik J, Obwaller A, Gruber F, et al. Anti-acanthamoeba efficacy and toxicity of miltefosine in an organotypic skin equivalent. J Antimicrob Chemother. 2009 Sep;64(3):539\u201345","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"309_CR14","doi-asserted-by":"crossref","first-page":"515\u201320","DOI":"10.1007\/s00436-011-2515-0","volume":"110","author":"ZA Polat","year":"2012","unstructured":"Polat ZA, Obwaller A, Vural A, et al. Efficacy of miltefosine for topical treatment of Acanthamoeba keratitis in Syrian hamsters. Parasitol Res. 2012 Feb;110(2):515\u201320.","journal-title":"Parasitol Res"},{"issue":"11","key":"309_CR15","doi-asserted-by":"crossref","first-page":"1743\u20136","DOI":"10.3201\/eid1411.070854","volume":"14","author":"AC Aichelburg","year":"2008","unstructured":"Aichelburg AC, Walochnik J, Assadian O, et al. Successful treatment of disseminated Acanthamoeba sp. infection with miltefosine. Emerg Infect Dis. 2008 Nov;14(11):1743\u20136.","journal-title":"Emerg Infect Dis"},{"key":"309_CR16","unstructured":"Barisani-Asenbauer T, Walochnik J, Mejdoubi L, et al. Sucessful management of recurrent Acanthamoeba keratitis using topical and systemic miltefosine. 2012 EVER meeting abstracts, abstract # eF095. Accessed 5. May 2013."},{"issue":"2","key":"309_CR17","first-page":"324\u201331","volume":"118","author":"YA Khan","year":"2011","unstructured":"Khan YA, Kashiwabuchi RT, Martins SA, et al. Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis: report of 3 cases. Ophthalmology. 2011 Feb;118(2):324\u201331.","journal-title":"Ophthalmology"},{"issue":"8","key":"309_CR18","doi-asserted-by":"crossref","first-page":"1021\u20133","DOI":"10.1097\/ICO.0b013e3181131ea9","volume":"26","author":"A Parthasarathy","year":"2007","unstructured":"Parthasarathy A, Tan DT. Deep lamellar keratoplasty for acanthamoeba keratitis. Cornea. 2007 Sep;26(8):1021\u20133.","journal-title":"Cornea"},{"key":"309_CR19","doi-asserted-by":"crossref","unstructured":"Dodds EM, Holland GN, Stanford MR, et al. Intraocular inflammation associated with ocular toxoplasmosis: relationships at initial examination. Am J Ophthalmol. 2008 Dec;146(6):856\u201365.e2.","DOI":"10.1016\/j.ajo.2008.09.006"},{"issue":"8","key":"309_CR20","doi-asserted-by":"crossref","first-page":"2037\u201345","DOI":"10.1007\/s00417-013-2334-3","volume":"251","author":"D Goldenberg","year":"2013","unstructured":"Goldenberg D, Goldstein M, Loewenstein A, Habot-Wilner Z. Vitreal, retinal, and choroidal findings in active and scarred toxoplasmosis lesions: a prospective study by spectral-domain optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2013 Aug;251(8):2037\u201345.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"309_CR21","doi-asserted-by":"crossref","first-page":"543\u201350","DOI":"10.1097\/ICU.0b013e328358bae5","volume":"23","author":"DV. Vasconcelos-Santos","year":"2012","unstructured":"Vasconcelos-Santos DV. Ocular manifestations of systemic disease: toxoplasmosis. Curr Opin Ophthalmol. 2012 Nov;23(6):543\u201350. doi: 10.1097\/ICU.0b013e328358bae5.","journal-title":"Curr Opin Ophthalmol"},{"issue":"4","key":"309_CR22","first-page":"837\u201348","volume":"2","author":"AL Vallochi","year":"2008","unstructured":"Vallochi AL, Goldberg AC, Falcai A, et al. Molecular markers of susceptibility to ocular toxoplasmosis, host and guest behaving badly. Clin Ophthalmol. 2008 Dec;2(4):837\u201348.","journal-title":"Clin Ophthalmol"},{"issue":"9","key":"309_CR23","doi-asserted-by":"crossref","first-page":"1761\u20138","DOI":"10.1016\/j.ophtha.2013.02.020","volume":"120","author":"S Sugita","year":"2013","unstructured":"Sugita S, Ogawa M, Shimizu N, Morio T, Ohguro N, Nakai K, Maruyama K, Nagata K, Takeda A, Usui Y, Sonoda KH, Takeuchi M, Mochizuki M. Use of a comprehensive polymerase chain reaction system for diagnosis of ocular infectious diseases. Ophthalmology. 2013 Sep;120(9):1761\u20138.","journal-title":"Ophthalmology"},{"issue":"5","key":"309_CR24","doi-asserted-by":"crossref","first-page":"926\u201331","DOI":"10.1016\/S0161-6420(03)00083-6","volume":"110","author":"MR Stanford","year":"2003","unstructured":"Stanford MR, See SE, Jones LV, et al. Antibiotics for toxoplasmic retinochoroiditis: an evidence-based systematic review. Ophthalmology. 2003 May;110(5):926\u201331.","journal-title":"Ophthalmology"},{"issue":"11","key":"309_CR25","doi-asserted-by":"crossref","first-page":"1306\u20138","DOI":"10.1136\/bjo.82.11.1306","volume":"82","author":"A Rothova","year":"1998","unstructured":"Rothova A, Bosch-Driessen LE, van Loon NH, et al. Azithromycin for ocular toxoplasmosis. Br J Ophthalmol. 1998 Nov;82(11):1306\u20138.","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"309_CR26","doi-asserted-by":"crossref","first-page":"1876\u201382","DOI":"10.1016\/j.ophtha.2005.05.025","volume":"112","author":"M Soheilian","year":"2005","unstructured":"Soheilian M, Sadoughi MM, Ghajarnia M, et al. Prospective randomized trial of trimethoprim\/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis. Ophthalmology. 2005 Nov;112(11):1876\u201382.","journal-title":"Ophthalmology"},{"issue":"9","key":"309_CR27","doi-asserted-by":"crossref","first-page":"1831\u20138","DOI":"10.1016\/j.ophtha.2010.01.028","volume":"117","author":"AF Lasave","year":"2010","unstructured":"Lasave AF, D\u00edaz-Llopis M, Muccioli C, et al. Intravitreal clindamycin and dexamethasone for zone 1 toxoplasmic retinochoroiditis at twenty-four months. Ophthalmology. 2010 Sep;117(9):1831\u20138. doi:10.1016\/j.ophtha.2010.01.028.","journal-title":"Ophthalmology"},{"issue":"1","key":"309_CR28","doi-asserted-by":"crossref","first-page":"41\u20136","DOI":"10.1016\/S0002-9394(02)01527-1","volume":"134","author":"C Silveira","year":"2002","unstructured":"Silveira C, Belfort R Jr, Muccioli C, Holland GN, Victora CG, Horta BL, Yu F, Nussenblatt RB. The effect of long-term intermittent trimethoprim\/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol. 2002 Jul;134(1):41\u20136.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"309_CR29","first-page":"265\u201372","volume":"16","author":"Despommier D. Toxocariasis","year":"2003","unstructured":"Despommier D. Toxocariasis: clinical aspects, epidemiology, medical ecology, and molecular aspects. Clin Microbiol Rev. 2003 Apr;16(2):265\u201372.","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"309_CR30","doi-asserted-by":"crossref","first-page":"649\u201356","DOI":"10.1007\/s00436-011-2536-8","volume":"110","author":"D Azam","year":"2012","unstructured":"Azam D, Ukpai OM, Said A, et al. Temperature and the development and survival of infective Toxocara canis larvae. Parasitol Res. 2012 Feb;110(2):649\u201356.","journal-title":"Parasitol Res"},{"issue":"2","key":"309_CR31","first-page":"321\u20136","volume":"24","author":"BB Chomel","year":"1993","unstructured":"Chomel BB, Kasten R, Adams C, et al. Serosurvey of some major zoonotic infections in children and teenagers in Bali, Indonesia. Southeast Asian J Trop Med Public Health. 1993 Jun;24(2):321\u20136.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"309_CR32","doi-asserted-by":"crossref","unstructured":"Magnaval JF, Michault A, Calon N, et al. Epidemiology of human toxocariasis in La R\u00e9union. Trans R Soc Trop Med Hyg. 1994 Sep-Oct;88(5):531\u20133.","DOI":"10.1016\/0035-9203(94)90148-1"},{"issue":"3","key":"309_CR33","doi-asserted-by":"crossref","first-page":"287\u201394","DOI":"10.1089\/108076801750295317","volume":"17","author":"T Barisani-Asenbauer","year":"2001","unstructured":"Barisani-Asenbauer T, Maca SM, Hauff W, Kaminski SL, Domanovits H, Theyer I, Auer H. Treatment of ocular toxocariasis with albendazole. J Ocul Pharmacol Ther. 2001 Jun;17(3):287\u201394.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"6","key":"309_CR34","doi-asserted-by":"crossref","first-page":"1211\u20137","DOI":"10.1016\/j.ophtha.2011.12.013","volume":"119","author":"D Woodhall","year":"2012","unstructured":"Woodhall D, Starr MC, Montgomery SP, Jones JL, Lum F, Read RW, Moorthy RS. Ocular toxocariasis: epidemiologic, anatomic, and therapeutic variations based on a survey of ophthalmic subspecialists. Ophthalmology. 2012 Jun;119(6):1211\u20137.","journal-title":"Ophthalmology"},{"key":"309_CR35","doi-asserted-by":"crossref","unstructured":"de Visser L, Rothova A, de Boer JH, et al. Diagnosis of ocular toxocariasis by establishing intraocular antibody production. Am J Ophthalmol. 2008 Feb;145(2):369\u201374.","DOI":"10.1016\/j.ajo.2007.09.020"},{"key":"309_CR36","unstructured":"Centers for Disease Control and Prevention (CDC). Ocular toxocariasis\u2014United States, 2009-2010. MMWR Morb Mortal Wkly Rep. 2011 Jun 10;60(22):734\u20136."}],"container-title":["Wiener Medizinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-014-0309-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10354-014-0309-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-014-0309-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T20:37:42Z","timestamp":1565987862000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10354-014-0309-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":36,"journal-issue":{"issue":"19-20","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["309"],"URL":"https:\/\/doi.org\/10.1007\/s10354-014-0309-6","relation":{},"ISSN":["0043-5341","1563-258X"],"issn-type":[{"value":"0043-5341","type":"print"},{"value":"1563-258X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10]]}}}